CAPLACIZUMAB
UNII 2R27AB6766

Substance Identification & Data

This profile provides standardized clinical and technical data for Caplacizumab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 2R27AB6766.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 915810-67-2 and the RxNorm Concept ID (RxCUI) 2110605. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

2R27AB6766

CAS Registry Number

915810-67-2

RxNorm Concept ID

2110605

Detailed Substance Profile

Preferred Name

CAPLACIZUMAB

Official standardized name for this substance within the FDA UNII nomenclature system.

Molecular Formula

2R27AB6766

The specific atomic composition represented as a molecular structure string.

NCI Thesaurus

C128625

National Cancer Institute reference terminology for clinical and research data.

INN ID

9511

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

AB-28

Identifier assigned by the United States Adopted Names Council.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Caplacizumab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

CAPLACIZUMAB

CAPLACIZUMAB-YHDP

Common Names & Synonyms

CAPLACIZUMAB [INN]

CAPLACIZUMAB [JAN]

CAPLACIZUMAB [MI]

CAPLACIZUMAB [USAN]

CAPLACIZUMAB [WHO-DD]

CAPLACIZUMAB YHDP [WHO-DD]

CAPLACIZUMAB-YHDP [PURPLE BOOK CDER]

Brand / Trade Names

CABLIVI

Systematic Nomenclature

IMMUNOGLOBULIN VH-LINKER-VH FRAGMENT, ANTI-(HOMO SAPIENS VWF (VON WILLEBRAND FACTOR) A1 DOMAIN), HUMANIZED MONOCLONAL ANTIBODY VH-LINKER-VH CHAIN (1-259) (HUMANIZED VH (HOMO SAPIENS IGHV3-23*04 (82.5%) -(IGHD)-IGHJ4*01 L123>Q (123) (8.8.21) (1-128)) -TRIALANYL LINKER (129-131)-(HUMANIZED VH (HOMO SAPIENS IGHV3-23*04 (82.5%) -(IGHD)-IGHJ4*01 L123>Q(254) (8.8.21) (132-259).

SYS

IMMUNOGLOBULIN, ANTI-(HUMAN VON WILLEBRAND'S BLOOD-COAGULATION FACTOR VIII DOMAIN A1) (HUMAN-LAMA GLAMA DIMERIC HEAVY CHAIN FRAGMENT PMP12A2H1)

SYS